位置:成果数据库 > 期刊 > 期刊详情页
难治性肾病的治疗-根据蛋白尿机制开发的新药和老药新用
  • ISSN号:2095-428X
  • 期刊名称:《中华实用儿科临床杂志》
  • 时间:0
  • 分类:R692[医药卫生—泌尿科学;医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:南京医科大学第一附属医院儿科,210029
  • 相关基金:国家自然科学基金面上项目(30570863,30872804,81170661);南京巾科技计划项目(201503003)
作者: 周国平
中文摘要:

各种难治性肾病综合征即使是同一种病理类型也有非常不同的发病机制,近年来有较多报道根据机制研究开发的肾病新药(如奥法木单抗和艾库组单抗)或老药新用(如辅酶Q10、半乳糖和维A酸),或者反过来,根据其他病种的新药用于肾病有效而发现肾病的新机制。现介绍几种新的成功用于难治性肾病临床的或蛋白尿实验动物的新型药物,或新的有效老药,并简要描述主要作用机制。希望这些信息对临床肾脏科医师选择用药和肾病领域的科研人员碰撞出思维灵感,并有实用价值。

英文摘要:

Even one the same pathological type of various kinds of refractory nephrotic syndrome has great dif-ferent pathogenesis. It is more reported in recent years that new nephrotic medications ( such as Ofatumumab and Eculi- zumab) or novel utilized old medications (such as CoQ10 ,galactose and retinoic acid) used in other diseases were re- searched and developed based on the mechanisms of nephrotic syndrome ,or new mechanisms were contrarily discovered when new medications used in other diseases were effectively used in refractory nephrotic syndrome. Here, the novel medications which were successfully used in clinic patients with refractory nephrotic syndrome, or laboratory proteinuric animal models, or the old medications with new and effective actions were introduced. Their mechanisms of drug actions were also briefly described. It is hoped that these information has practical value for the medication selection by clinical nephrologist and for the collision of research idea inspiration by investigators in nephropathy research area.

同期刊论文项目
期刊论文 29 会议论文 8
同项目期刊论文
期刊信息
  • 《中华实用儿科临床杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:郭学鹏
  • 地址:河南省新乡市金穗大道东段新乡医学院
  • 邮编:453003
  • 邮箱:syqk@xxmc.edu.cn
  • 电话:0373-3029144 3831456
  • 国际标准刊号:ISSN:2095-428X
  • 国内统一刊号:ISSN:10-1070/R
  • 邮发代号:36-102
  • 获奖情况:
  • 中国科技论文统计源期刊,临床医学类核心期刊,河南省优秀科技期刊二等奖
  • 国内外数据库收录:
  • 波兰哥白尼索引,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:5061